<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04771650</url>
  </required_header>
  <id_info>
    <org_study_id>5688</org_study_id>
    <secondary_id>1R01AA028507</secondary_id>
    <nct_id>NCT04771650</nct_id>
  </id_info>
  <brief_title>A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users</brief_title>
  <acronym>CAMI-HI</acronym>
  <official_title>Addressing Alcohol-Use Related Health Disparities: A Hybrid Effectiveness Implementation Study of a Culturally Adapted MI for Latino/a Alcohol and Drug Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University Charles River Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University Charles River Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alcohol use is a significant problem among Latinxs and immigration-related stress increases&#xD;
      risk for substance use. A theoretically-based cultural adaptation of motivational&#xD;
      interviewing (CAMI) that specifically integrated discussion of immigration-related stressors&#xD;
      (e.g., stigma, social isolation) resulted in significant reductions in alcohol-related harms&#xD;
      for those Latinx heavy drinkers with high discrimination compared to standard MI, and reduced&#xD;
      anxiety and depressive symptoms one year later compared to MI. Rigorous tests that examine&#xD;
      theoretically-informed adaptation of efficacious addiction interventions are not common, yet&#xD;
      are needed to advance implementation science. This Hybrid Type 1 Effectiveness-Implementation&#xD;
      study will investigate the feasibility of implementing CAMI in a real-world clinical setting.&#xD;
      The key questions are: Would CAMI have positive effects among individuals who use both drugs&#xD;
      and alcohol? How do providers view this intervention? The investigators will collaborate with&#xD;
      a primary care center that serves a mainly Latinx client population to train their Community&#xD;
      Wellness Advocates (CWAs) to deliver CAMI to patients who are heavy drinkers. The&#xD;
      investigators will conduct a concurrent investigation on the process of implementing CAMI in&#xD;
      primary care - a two-arm randomized clinical effectiveness trial will enroll Latinx heavy&#xD;
      drinkers (18 years or older) in primary care who use alcohol (and may use other drugs) - and&#xD;
      follow them for 12 months after the intervention. Specific Aims are: (1) To examine the&#xD;
      impact of CAMI plus a booster session (vs. assessment only) on outcomes: % heavy drinking&#xD;
      days, frequency of alcohol-related consequences, depressive/anxiety symptoms, and number of&#xD;
      illicit drug use days, using a Hybrid Type 1 Effectiveness-Implementation design and (2) To&#xD;
      gather indicators of implementation outcome from multiple stakeholders using a mixed-methods&#xD;
      approach. The investigators will follow Curran's framework to evaluate the process of&#xD;
      implementation and Proctor's framework to measure implementation outcomes. This study, a&#xD;
      first to examine the acceptability of culturally-adapted addiction treatments in primary care&#xD;
      settings, will answer essential questions on implementing evidence-based care for Latinxs&#xD;
      that can improve health disparities related to substance use. Long term goals are to&#xD;
      translate the lessons from this Hybrid study to the broader community to focus on population&#xD;
      health for all primary care patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alcohol use is a significant problem among Latinxs because of the disproportionate burden of&#xD;
      physical harms and negative consequences associated with substance use relative to other&#xD;
      racial/ethnic groups. Factors associated with the stress related to being an immigrant&#xD;
      increase risk for substance use. A theoretically-based cultural adaptation of motivational&#xD;
      interviewing (CAMI) that specifically integrated discussion of stressors related to&#xD;
      immigration (e.g., discrimination, stigma, social isolation) resulted in significant&#xD;
      reductions in harms related to alcohol for those Latinx heavy drinkers with high&#xD;
      discrimination compared to standard MI, and reduced anxiety and depressive symptoms one year&#xD;
      later compared to MI. Rigorous tests that examine theoretically-informed adaptation of&#xD;
      efficacious interventions for addictions are not common, yet are needed to advance&#xD;
      implementation science because they address questions that are the basis for successful&#xD;
      implementation. The proposed Hybrid Type 1 Effectiveness-Implementation study is an important&#xD;
      next step in this line of research, which is to investigate the feasibility of implementing&#xD;
      the CAMI intervention in a real-world clinical setting. The key questions are: Would CAMI&#xD;
      have positive effects among individuals who use both drugs and alcohol? How do providers view&#xD;
      this intervention? The investigators will collaborate with a primary care center that serves&#xD;
      a mainly Latinx client population to train their Community Wellness Advocates (CWAs) to&#xD;
      deliver the CAMI to patients who are heavy drinkers. The investigators will conduct a&#xD;
      concurrent investigation on the process of implementing the CAMI in primary care - a two-arm&#xD;
      randomized clinical effectiveness trial will enroll Latinx heavy drinkers (18 years or older)&#xD;
      in primary care who use alcohol (and may use other drugs) - and follow them for 12 months&#xD;
      after the intervention. Specific Aims are: (1) To examine the impact of CAMI plus an in-&#xD;
      person booster session (vs. assessment only) on outcomes: % heavy drinking days, frequency of&#xD;
      alcohol- related consequences, depressive/anxiety symptoms, and number of illicit drug use&#xD;
      days, using a Hybrid Type 1 Effectiveness-Implementation design and (2) To gather indicators&#xD;
      of implementation outcome from multiple stakeholders using a mixed-methods approach. The&#xD;
      investigators will follow Curran's framework to evaluate the process of implementation and&#xD;
      Proctor's framework to measure implementation outcomes: acceptability, adoption, intervention&#xD;
      appropriateness, feasibility, overall cost (i.e., CAMI vs. assessment only), and treatment&#xD;
      fidelity. This study, a first to examine the acceptability of culturally-adapted addiction&#xD;
      treatments in primary care settings, will answer essential questions on implementing&#xD;
      evidence-based care for Latinxs that can improve health disparities related to substance use.&#xD;
      Long term goals are to translate the lessons from the proposed Hybrid study to the broader&#xD;
      community to focus on population health for all primary care patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Clinical effectiveness trial that tests two conditions (CAMI plus booster + standard care compared to assessment + standard care). Health outcomes are reduced drinking, related harms and improvement of mental health. Follow-up at 3,6, and 12 months.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants will be randomized to one of two conditions. They will be unaware of their randomization condition. The Research assistant conducting follow-ups will be unaware of the participant's treatment condition.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>3 month follow-up</time_frame>
    <description>% heavy drinking days (4 or 5 drinks/day female/male, respectively)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alcohol-related consequences</measure>
    <time_frame>3 month follow-up</time_frame>
    <description>Frequency of alcohol related consequences (e.g., driving under the influence).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent drug use days</measure>
    <time_frame>3 month follow-up</time_frame>
    <description>% drug use days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>% heavy drinking days (4 or 5 drinks/day female/male, respectively)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>12 month follow-up</time_frame>
    <description>% heavy drinking days (4 or 5 drinks/day female/male, respectively)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol-related consequences</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>Frequency of alcohol related consequences (e.g., driving under the influence).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol-related consequences</measure>
    <time_frame>12 month follow-up</time_frame>
    <description>Frequency of alcohol related consequences (e.g., driving under the influence).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Center for Epidemiological Studies - Depression</measure>
    <time_frame>3 month follow-up</time_frame>
    <description>Level of depressive symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Center for Epidemiological Studies - Depression</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>Level of depressive symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Center for Epidemiological Studies - Depression</measure>
    <time_frame>12 month follow-up</time_frame>
    <description>Level of depressive symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
    <time_frame>3 month follow-up</time_frame>
    <description>Level of anxiety symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>Level of anxiety symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Anxiety Inventory</measure>
    <time_frame>12 month follow-up</time_frame>
    <description>Level of anxiety symptomatology in the past week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent drug use days</measure>
    <time_frame>6 month follow-up</time_frame>
    <description>% drug use days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent drug use days</measure>
    <time_frame>12 month follow-up</time_frame>
    <description>% drug use days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <condition>Drug Use</condition>
  <condition>Psychological Distress</condition>
  <arm_group>
    <arm_group_label>CAMI/CAMI booster</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Culturally Adapted Motivational Interview. Participants will receive a single session, 75 minute addiction counseling discussion that focuses on the causes of addictive behavior. They will receive a CAMI booster session at 2 months and standard care in a primary care setting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Assessment plus standard care. Participants will complete an assessment, including measures on drinking and drug use. They will also receive standard care in a primary care setting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CAMI</intervention_name>
    <description>The CAMI is a culturally adapted motivational interview. It is a single 75 minute session that focuses on promoting motivation to change drinking and drug use behavior.</description>
    <arm_group_label>CAMI/CAMI booster</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  4/5 or more drinks/occasion (female/male, respectively) 5+ days/month&#xD;
&#xD;
          -  AUDIT score of 8+ for men and 6+ for women&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Identify as Latinx&#xD;
&#xD;
          -  First or second-generation immigrants&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current psychotic symptoms&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Currently in treatment for substance use disorder&#xD;
&#xD;
          -  Patients who have been enrolled in the Complex Care Management (CCM) Program for 1&#xD;
             month or longer.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina S Lee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina S Lee, PhD</last_name>
    <phone>617 353 1415</phone>
    <email>leecs@bu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lee CS, Colby SM, Magill M, Almeida J, Tavares T, Rohsenow DJ. A randomized controlled trial of culturally adapted motivational interviewing for Hispanic heavy drinkers: Theory of adaptation and study protocol. Contemp Clin Trials. 2016 Sep;50:193-200. doi: 10.1016/j.cct.2016.08.013. Epub 2016 Aug 24.</citation>
    <PMID>27565832</PMID>
  </reference>
  <reference>
    <citation>Lee CS, Colby SM, Rohsenow DJ, Martin R, Rosales R, McCallum TT, Falcon L, Almeida J, Cort√©s DE. A randomized controlled trial of motivational interviewing tailored for heavy drinking latinxs. J Consult Clin Psychol. 2019 Sep;87(9):815-830. doi: 10.1037/ccp0000428.</citation>
    <PMID>31403817</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 11, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University Charles River Campus</investigator_affiliation>
    <investigator_full_name>Christina Lee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Alcohol</keyword>
  <keyword>Drug</keyword>
  <keyword>Latinx</keyword>
  <keyword>Treatment</keyword>
  <keyword>Psychological distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

